Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.
Dautruche A, Belin L, Cottu P, Bontemps P, Lemanski C, de la Lande B, Baumann P, Missohou F, Lévy C, Peignaux K, Reynaud-Bougnoux A, Denis F, Gobillion A, Pernin V, Kirova Y. Dautruche A, et al. Among authors: de la lande b. Cancer Radiother. 2018 May;22(3):222-228. doi: 10.1016/j.canrad.2017.10.004. Epub 2018 Apr 9. Cancer Radiother. 2018. PMID: 29650388
A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results.
Rouëssé J, de la Lande B, Bertheault-Cvitkovic F, Serin D, Graïc Y, Combe M, Leduc B, Lucas V, Demange L, Nguyen TD, Castèra D, Krzisch C, Villet R, Mouret-Fourme E, Garbay JR, Noguès C; Centre René Huguenin Breast Cancer Group. Rouëssé J, et al. Among authors: de la lande b. Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1072-80. doi: 10.1016/j.ijrobp.2005.10.011. Int J Radiat Oncol Biol Phys. 2006. PMID: 16504757 Clinical Trial.
[Ductal carcinoma in situ: role of the boost].
Azria D, Auvray H, Barillot I, Baumann P, Benyoucef A, Bons-Rosset F, Bontemps P, Bourgier C, Breton-Callu C, Cowen D, Cretin J, Delalande B, Denis F, Ellis S, Gaci Z, Hannoun-Lévy JM, Hasbini A, Hennequin C, Lagrange JL, Lartigau E, Latorzeff I, Le Blanc-Onfroy M, Lecouillard I, Lemanski C, Levy C, Maingon P, Marchal C, Monnier A, Pradier O, Racadot S, Romestaing P, Serin D, Simon JM, Teyssier E, Tallet A, Tolédano A, Belkacémi Y. Azria D, et al. Cancer Radiother. 2008 Nov;12(6-7):571-6. doi: 10.1016/j.canrad.2008.07.005. Epub 2008 Aug 13. Cancer Radiother. 2008. PMID: 18703372 Review. French.
Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.
Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, Gardner M, Moisson P, Villette S, Lerebours F, Munck JN, Labib A. Le Scodan R, et al. Among authors: de la lande b. J Clin Oncol. 2009 Mar 20;27(9):1375-81. doi: 10.1200/JCO.2008.19.5396. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204198
Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P, Gardner M, De la Lande B, Lasry S, Labib A, Le Scodan R. Daveau C, et al. Among authors: de la lande b. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):337-42. doi: 10.1016/j.ijrobp.2009.08.053. Epub 2010 Feb 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171795
[Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].
Le Scodan R, Bruant S, Selz J, Bollet MA, Daveau C, de la Lande B, Lerebours F, Labib A, Stevens D. Le Scodan R, et al. Among authors: de la lande b. Cancer Radiother. 2011 Dec;15(8):675-82. doi: 10.1016/j.canrad.2011.04.004. Epub 2011 Aug 9. Cancer Radiother. 2011. PMID: 21831686 French.
28 results